CAR-T cells for cancer treatment: current design and next frontiers (2020)
- Authors:
- USP affiliated authors: ANTONIETTO, KAMILLA SWIECH - FCFRP ; FARIAS, KELEN CRISTINA RIBEIRO MALMEGRIM DE - FCFRP ; COVAS, DIMAS TADEU - FMRP
- Unidades: FCFRP; FMRP
- DOI: 10.1007/978-1-0716-0146-4_1
- Subjects: IMUNOTERAPIA; NEOPLASIAS; IMUNOLOGIA
- Keywords: CAR-T cells; Chimeric antigen receptor; Immunotherapy; T cells
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher: Humana Press
- Publisher place: New York
- Date published: 2020
- Source:
- Título do periódico: Chimeric Antigen Receptor T Cell: Development and Production
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
PICANÇO-CASTRO, Virgínia et al. CAR-T cells for cancer treatment: current design and next frontiers. Chimeric Antigen Receptor T Cell: Development and Production. Tradução . New York: Humana Press, 2020. . Disponível em: https://doi.org/10.1007/978-1-0716-0146-4_1. Acesso em: 04 maio 2024. -
APA
Picanço-Castro, V., Swiech, K., Farias, K. C. R. M. de, & Covas, D. T. (2020). CAR-T cells for cancer treatment: current design and next frontiers. In Chimeric Antigen Receptor T Cell: Development and Production. New York: Humana Press. doi:10.1007/978-1-0716-0146-4_1 -
NLM
Picanço-Castro V, Swiech K, Farias KCRM de, Covas DT. CAR-T cells for cancer treatment: current design and next frontiers [Internet]. In: Chimeric Antigen Receptor T Cell: Development and Production. New York: Humana Press; 2020. [citado 2024 maio 04 ] Available from: https://doi.org/10.1007/978-1-0716-0146-4_1 -
Vancouver
Picanço-Castro V, Swiech K, Farias KCRM de, Covas DT. CAR-T cells for cancer treatment: current design and next frontiers [Internet]. In: Chimeric Antigen Receptor T Cell: Development and Production. New York: Humana Press; 2020. [citado 2024 maio 04 ] Available from: https://doi.org/10.1007/978-1-0716-0146-4_1 - Production of recombinant coagulation factors:: are humans the best host cells?
- A Fully-closed and automated hollow fiber bioreactor for clinical-grade manufacturing of human Mesenchymal stem/stromal cells
- Feasibility of the taylor vortex flow bioreactor for mesenchymal stromal cell expansion on microcarriers
- Production of coagulation factor VII in human cell lines Sk-Hep-1 and HKB-11
- Stirred tank bioreactor culture combined with serum-/xenogeneic-free culture medium enables an efficient expansion of umbilical cord-derived mesenchymal stem/stromal cells
- Mesenchymal stromal cells maintain the major quality attributes when expanded in different bioreactor systems
- DPP-4 inhibition leads to decreased pancreatic inflammatory profile and increased frequency of regulatory T cells in experimental type 1 diabetes
- Hypoxia and 3D combined priming improves in vitro Paracrine angiogenic potential of UC-MSC
- Engineered CD19-CAR NK cells as an off-the-shelf alternative to B cell leukemia and lymphoma treatment
- Emerging CAR T cell therapies: clinical landscape and patent technological routes
Informações sobre o DOI: 10.1007/978-1-0716-0146-4_1 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 | 003007995.pdf |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
